People · Operator
Named in public records as an officer, director or promoter · active 2015–2018 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Gladius Pharmaceuticals Corp | — | Biotechnology | Seed | $3.8M | $134.2M | 2015 |
Michael Atkin at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Michael Atkin on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Jens Eckstein | 1 | 8 |
| Daniel Hetu | 1 | 3 |
| Nathalie Chauret | 1 | 1 |
| Larry Sutton | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.